ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 189 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $680,754 | +7.7% | 11,725 | -0.1% | 0.12% | +12.7% |
Q2 2023 | $631,964 | +42.3% | 11,740 | +5.0% | 0.11% | +41.0% |
Q1 2023 | $444,109 | -65.6% | 11,181 | -69.6% | 0.08% | -45.1% |
Q2 2021 | $1,290,000 | +124.7% | 36,818 | +295.3% | 0.14% | +73.2% |
Q4 2020 | $574,000 | +121.6% | 9,315 | +46.4% | 0.08% | +60.8% |
Q1 2020 | $259,000 | -62.1% | 6,361 | -42.6% | 0.05% | -44.6% |
Q4 2019 | $683,000 | -16.1% | 11,075 | -0.9% | 0.09% | -20.0% |
Q3 2019 | $814,000 | -60.1% | 11,175 | -54.9% | 0.12% | -57.2% |
Q2 2019 | $2,039,000 | +4.0% | 24,805 | -10.7% | 0.27% | -0.7% |
Q1 2019 | $1,960,000 | +50.3% | 27,780 | -4.1% | 0.27% | +34.2% |
Q4 2018 | $1,304,000 | -22.5% | 28,955 | -2.7% | 0.20% | -8.2% |
Q3 2018 | $1,683,000 | +0.5% | 29,760 | +18.7% | 0.22% | -8.3% |
Q2 2018 | $1,675,000 | +11.1% | 25,075 | -3.2% | 0.24% | +11.6% |
Q1 2018 | $1,508,000 | +108.0% | 25,900 | +130.2% | 0.22% | +117.2% |
Q4 2017 | $725,000 | – | 11,250 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |